Next Article in Journal / Special Issue
Targeting MYC Dependence by Metabolic Inhibitors in Cancer
Previous Article in Journal
DNA Replication Origins and Fork Progression at Mammalian Telomeres
Previous Article in Special Issue
Modeling and Targeting MYC Genes in Childhood Brain Tumors
Article Menu

Export Article

Open AccessReview
Genes 2017, 8(4), 113; doi:10.3390/genes8040113

The MYCN Protein in Health and Disease

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm SE-171 77, Sweden
*
Author to whom correspondence should be addressed.
Academic Editor: Daitoku Sakamuro
Received: 31 January 2017 / Revised: 23 March 2017 / Accepted: 27 March 2017 / Published: 30 March 2017
(This article belongs to the Special Issue MYC Networks)
View Full-Text   |   Download PDF [1194 KB, uploaded 11 April 2017]   |  

Abstract

MYCN is a member of the MYC family of proto-oncogenes. It encodes a transcription factor, MYCN, involved in the control of fundamental processes during embryonal development. The MYCN protein is situated downstream of several signaling pathways promoting cell growth, proliferation and metabolism of progenitor cells in different developing organs and tissues. Conversely, deregulated MYCN signaling supports the development of several different tumors, mainly with a childhood onset, including neuroblastoma, medulloblastoma, rhabdomyosarcoma and Wilms’ tumor, but it is also associated with some cancers occurring during adulthood such as prostate and lung cancer. In neuroblastoma, MYCN-amplification is the most consistent genetic aberration associated with poor prognosis and treatment failure. Targeting MYCN has been proposed as a therapeutic strategy for the treatment of these tumors and great efforts have allowed the development of direct and indirect MYCN inhibitors with potential clinical use. View Full-Text
Keywords: MYCN; embryonal development; childhood tumors; neuroblastoma; targeted therapy MYCN; embryonal development; childhood tumors; neuroblastoma; targeted therapy
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Ruiz-Pérez, M.V.; Henley, A.B.; Arsenian-Henriksson, M. The MYCN Protein in Health and Disease. Genes 2017, 8, 113.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Genes EISSN 2073-4425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top